4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-134072
CEO & President acquired 145,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox John CEO & President | 2024-12-04 | Grant or award | +145,300 | 150,300 | D | ||
| Derivatives | |||||||
| Cox John CEO & President | 2024-12-04 | Grant or award · Stock option (right to buy) | +232,100 | 232,100 | D | ||
Loading xslF345X05/ownership.xml…